Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Should You Buy Ocugen Stock?

TheMotleyFool

0 0

Some stocks come seemingly out of nowhere but are huge winners. You can put Ocugen (NASDAQ: OCGN) in that category. As of Dec. 21, 2020, its shares were down 43% year to date. The next day, though, Ocugen announced that it was teaming up with Bharat Biotech to co-develop COVID-19 vaccine candidate Covaxin for the U.S. market.

Since then, the stock has skyrocketed more than 3,600% and even doubled just last week. Previously little-known Ocugen now ranks among the most popular stocks on Robinhood -- and it's caught the attention of many investors who don't trade on Robinhood, too.

Should you buy Ocugen stock now? Here are the arguments both for and against the high-flying biotech stock.

Source Fool.com

Like: 0

OCGN

Teilen